Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

NCT06742996

Conditions
B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Ucsf Fresno Fresno, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
View all 155 locations
View Trial Details
Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

NCT06542250

Conditions
B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site Hackensack, New Jersey, United States
View all 31 locations
View Trial Details
Recruiting

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

NCT05976763

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
View all 237 locations
View Trial Details
Recruiting

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

NCT07003295

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View Trial Details
Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

NCT04792489

Conditions
Central Nervous System Lymphoma, Central Nervous System Neoplasms, Hemic and Lymphatic Diseases, +22 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Health La Jolla, California, United States
View all 32 locations
View Trial Details
Recruiting

Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma

NCT06558604

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Az Sint-Jan Brugge - Oostende Av Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Chu de Liege Liège, Belgium
  • Chu Ucl Namur - Site Godinne Yvoir, Belgium
View all 16 locations
View Trial Details

Related conditions